PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F14JG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,618
Award facts
- Contract value 100% obligated
- $25,617.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $25,617.60 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award is issued under a larger Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, which carries a significant potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support mechanism.
AmerisourceBergen Drug Corp leverages this prime IDC to supply an extensive portfolio of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's federal procurement history demonstrates consistent capability in fulfilling medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded delivery orders with firm fixed pricing structures. The DLA Medical Supply Chain is pursuing a multi-award strategy through its Pharmaceutical Prime Vendor Global Program Generation V initiative, with plans to establish separate regional contracts involving multiple contractors, positioning AmerisourceBergen among the key suppliers for federal military medical procurement.
Quick answers
Who was awarded contract SPE2D826F14JG?
SPE2D826F14JG was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 19, 2026.
How much is contract SPE2D826F14JG worth?
The government has obligated $25,618 on SPE2D826F14JG.
Is contract SPE2D826F14JG an order under another contract?
Yes. SPE2D826F14JG is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F14JG competed?
The extent of competition for SPE2D826F14JG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award